Financing, Equity Capital Markets
Milestone Pharmaceuticals, Inc.
02/24
|
$30.0 Million
Âé¶¹´«Ã½ served as sole bookrunner for Milestone Pharmaceuticals, Inc. on a confidentially marketed follow-on offering
Sub-Type
Confidentially Marketed Follow-On Offering
Sector
Sub-Sector
Biopharma